How Tumor Cells Make Use of CD44

Cell Communication and Adhesion

Volumn 6, Issue 2-3, 1998, Pages 141-147

  Herrlich, Peter ^a   Sleeman, Jonathan ^a   Wainwright, David ^a   König, Harald ^a   Sherman, Larry ^a,c   Hilberg, Frank ^b   Ponta, Helmut ^a  

^a KARLSRUHE INSTITUTE OF TECHNOLOGY   (Germany)

^b Fa Bender + Co GmbH   (Austria)

^c UNIVERSITY OF CINCINNATI   (United States)

Author keywords

CD44 variants; Growth factor presentation; Limb formation; Tumor metastasis

Indexed keywords

CD44V ANTIGEN; GROWTH FACTOR; HEPARAN SULFATE;

ALTERNATIVE RNA SPLICING; AMINO ACID SEQUENCE; ANTIGEN EXPRESSION; CELL PROLIFERATION; CONFERENCE PAPER; EMBRYO DEVELOPMENT; EXON; HUMAN; LIMB BUD; MESENCHYME CELL; METASTASIS; PRIORITY JOURNAL; TUMOR CELL;

ANIMALS; ANTIGENS, CD44; NEOPLASM CIRCULATING CELLS; NEOPLASM METASTASIS; RECEPTORS, FIBROBLAST GROWTH FACTOR;

EID: 0031796198     PISSN: 10615385     EISSN: None     Source Type: Journal    
DOI: 10.3109/15419069809004470     Document Type: Article

References (52)

1. Angel, P. et al. (1987) Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated transacting factor. Cell 49, 729-739.
2. Arch, R. et al. (1992) Participation in normal immune responses of a splice variant of CD44 that encodes a metastasis-inducing domain. Science 257, 682-685.
3. Bartolazzi, A. et al. (1996) Glycosylation of CD44 is implicated in CD44-mediated cell adhesion to hyaluronan. J. Cell Biol. 132, 1199-1208.
4. Bennett, K.L. et al. (1995a) CD44 isoforms containing exon v3 are responsible for the presentation of heparin-binding growth factor. J. Cell Biol 128, 687-698.
5. Bennett, K.L. et al. (1995b) Regulation of CD44 binding to hyaluronan by glycosylation of variably spliced exons. J. Cell Biol. 131, 1623-1633.
6. Crossley, P.H. et al. (1996) Role for FGF8 in the induction, initiation, and maintenance of chick limb development. Cell 84, 127-136.
7. Culty, M et al. (1992) The hyaluronan receptor (CD44) participates in the uptake and degradation of hyaluronan. J. Cell Biol. 116, 1055-1062.
8. DeGrendele, H.C et al. (1997) Requirement for CD44 in activated T cell extravasation into an inflammatory site. Science 278, 672-675.
9. Günthert, U. et al. (1991) A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 65, 13-24.
10. Herrlich, P. et al. (1993) CD44 and splice variants of CD44 in normal differentiation and tumor progression. In: "Cell adhesion molecules" M E. Hemler and E. Mihich, eds., Plenum Press, New York and London, pp. 265-288.
11. Hofmann, M. et al. (1993) A link between RAS and metastatic behavior of tumor cells: ras induces CD44 promoter activity and leads to low-level expression of metastasis-specific variants of CD44 in CREF cells. Cancer Res. 53, 1516-1521.
12. Jackson, D.G. et al. (1992) Multiple variants of the human lymphocyte homing receptor CD44 generated by insertions at a single site in the extracellular domain. J. Biol. Chem. 267, 4732-4739.
13. Jackson, D.G. et al. (1995) Proteoglycan forms on the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon. J. Cell Biol. 128, 673-685.
14. Jalkanen, S. et al. (1987) Lymphocyte recognition of high endothelium. antibodies to distinct epitopes of an 85-95 kD glycoprotein antigen differentially inhibit lymphocyte binding to lymph node, mucosal, or synovial endothelial cells. J Cell Biol. 105, 983-990.
15. Jalkanen, S et al. (1988) Biochemical properties of glycoproteins involved in lymphocyte recognition of high endothelial venules in man. J. Immunol. 141, 1615-1623.
16. Katoh, S. et al. (1995) Glycosylation of CD44 negatively regulates its recognition of hyaluronan. J. Exp. Med. 182, 419-429.
17. Kaufmann, M. et al. (1995) CD44 variant exon epitopes in primary breast cancer and length of survival. The Lancet 345, 615-619.
18. Kaya, G. et al (1997) Selective suppression of CD44 in keratinocyles of mice bearing an antisense CD44 transgene driven by a tissue-specific promoter disrupts hyaluronate metabolism in the skin and impairs keratinocyte proliferation. Genes Dev. 11, 996-1007.
19. König, H. et al. (1998) Coupling of signal transduction to alternative pre-m RNA splicing by a composite splice regulator EMBO J. (in press)
20. Koopman, G. et al. (1993) Activated human lymphocytes and aggressive Non-Hodgkin lymphomas express a homologue of the rat metastasis-associated variant of CD44. J Exp. Med 177, 897-904
21. Lamb, R.F. et al. (1997) AP-1-mediated invasion requires increased expression of the hyaluronan receptor CD44. Mol. Cell Biol. 17, 963-976
22. Lee, W. et al. (1987) Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements. Cell 49, 741-752.
23. Lesley, J. et al. (1995) Variant cell lines selected for alterations in the function of the hyaluronan receptor CD44 show differences in glycosylation. J. Exp. Med. 182, 431-437.
24. Lokeshwar, V.B. and Bourguignon, (1991) Post-translational protein modification and expression of ankyrin-binding site(s) in GP85 (Pgp-1/CD44) and its biosynthetic precursors during T-lymphoma membrane biosynthesis. J. Biol. Chem. 266, 17983-17989.
25. Lokeshwar, V.B. et al. (1994) Ankyrin-binding domain of CD44(GP85) is required for the expression of hyaluronic acid-mediated adhesion function. J. Cell Biol. 126, 1099-1109.
26. Mulder, J -W.R. et al. (1994) Colorectal cancer prognosis and expression of exon-v6-contamins CD44 proteins. The Lancet 344, 1470-1472.
27. Naor, D. et al. (1997) CD44: Structure, function and association with the malignant process. Adv. Cancer Res. 71, 241-319.
28. Niswander, L. and Martin, G.R. (1992) Fgf-4 expression during gastrulation, myogenesis, limb and tooth development in the mouse. Development 114, 755-768
29. Niswander, L. et al. ( 1993) FGF-4 replaces the apical ectodermal ridge and directs outgrowth and patterning of the limb. Cell 75, 579-587.
30. Peach, R.J. et al (1993) Identification of hyaluronic acid binding sites in the extracellular domain of CD44 J. Cell Biol. 122, 257-264
31. Rudy, W. et al. (1993) The two major CD44 proteins expressed on a metastatic rat tumor cell line are derived from different splice variants: each one individually suffices to confer metastatic behavior Cancer Res. 53, 1262-1268.
32. Saunders, J.W. Jr. (1948) The proximal-distal sequence of origin of the parts of the chick limb and the role of the ectoderm. J. Exp. Zool. 108, 363-404.
33. Schmits, R et al. (1997) CD44 regulates hematopoietic progenitor distribution, granuloma formation, and tumorigenicity. Blood 90, 2217-2233.
34. Screaton, G.R. et al. (1992) Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc. Natl. Acad. Sci. USA 89, 12160-12164
35. Sherman, L. et al. (1998) A splice variant of CD44 expressed in the apical ectodermal ridge presents FGFs to limb mesenchyme and is required for limb outgrowth. Genes Dev (in press)
36. Sleeman, J. et al. (1996a) Regulated clustering of variant CD44 proteins increases their hyaluronate binding capacity. J. Cell Biol. 135, 1139-1150.
37. Sleeman, J.P. et al. (1996b) Hyaluronate-independent metastatic behavior of CD44 variant-expressing pancreatic carcinoma cells. Cancer Res. 56, 3134-3141.
38. Sleeman, J. et al. (1997) Variant exons v6 and v7 together expand the repertoire of glycosaminoglycans bound by CD44. J. Biol. Chem. 272, 31837-31841.
39. Sleeman, J. et al. (1998) CD44 variant exon v5 encodes a tyrosine which is sulphated, Eur J. Biochem. (in press)
40. Stauder, R. et al. (1995) CD44 variant isoforms in non- Hodgkin's lymphoma: a new independent prognostic factor. Blood 85, 2885-2899.
41. Sy, M.-S. et al. (1991) Distinct effects of two CD44 isoforms on tumor growth in vivo. J. Exp. Med. 174, 859-866.
42. Sy, M.-S. et al. (1992) Inhibition of tumor growth in vivo with a soluble CD44-immunoglobulin fusion protein. J. Exp. Med. 176, 623-627.
43. lck in T lymphocytes. J. Biol. Chem. 271, 2863-2867.
44. Tanaka, Y. et al. (1993) T-cell adhesion induced by proteoglycan-immobihzed cytokine MIP-1b Nature 361, 79-82.
45. Tölg, C. et al. (1993) Splicing choice from ten variant exons establishes CD44 variability. Nucleic Acids Res. 21, 1225-1229.
46. Wainwright, D. et al. (1996) A splice variant of CD44 expressed in the rat apical ectodermal ridge contributes to limb out-growth. Ann. NY Acad. Sci. 785, 345-349.
47. Weiss, J M et al. (1997) An essential role for CD44 variant isoforms in epidermal Langerhans cell and blood dendritic cell function. J. Cell Biol. 137, 1137-1147.
48. Wirth, K. et al. (1993) Expression of CD44 isoforms carrying metastasis-associated sequences in newborn and adult rats. Eur. J. Cancer 29A, 1177-1183.
49. Yang, B. et al. (1994) Identification of a common hyaluronan binding motif in the hyaluronan binding proteins RHAMM, CD44 and link protein. EMBO J 13, 286-296.
50. Zahalka, M.A. et al. (1995) Lymph node (but not spleen) invasion by murine lymphoma is both CD44- and hyaluronate-dependent. J. Immunol. 154, 5345-5355.
51. Zheng, J. et al. (1995) Keratinocyte growth factor is a bifunctional regulator of HPV16 DNA-immortalized cervical epithelial cells. J Cell Biol. 129, 843-851.
52. Zhou, D.F.H et al. (1989) Molecular cloning and expression of Pgp-1 - The mouse homolog of the human H-CAM (Hermes) lymphocyte homing receptor. J. Immunol. 143, 3390-3395.